Translational Oncology Oncology
CD74 links MHC class II risk to tumor immune microenvironment remodeling across the Sjögren-to-lymphoma axis
The publisher did not provide an abstract — full text is available via the link below.
Translational Oncology Oncology
The publisher did not provide an abstract — full text is available via the link below.